Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $50
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Justin Kim maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $44 to $50.
Oppenheimer analyst Justin Kim maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $44 to $50.